These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6361804)

  • 21. Membrane transport of alkylating agents.
    Goldenberg GJ; Begleiter A
    Pharmacol Ther; 1980; 8(2):237-74. PubMed ID: 6992155
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxicity and antineoplastic activity of asalei (ethyl ester of acetyl-sarcolysine-L-leucine).
    Larionov LF; Bukharova IK; Shamaeva EM
    Fed Proc Transl Suppl; 1966; 25(1):77-8. PubMed ID: 5215810
    [No Abstract]   [Full Text] [Related]  

  • 23. Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):171-83. PubMed ID: 441510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid conferred protection against melphalan interference with melphalan therapy by L-leucine, a competitive substrate for transport.
    Vistica DT; Rabon A; Rabinovitz M
    Cancer Lett; 1979 Jan; 6(1):7-13. PubMed ID: 544013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport of melphalan by sensitive and resistant L1210 cells.
    Redwood WR; Colvin M
    Cancer Res; 1980 Apr; 40(4):1144-9. PubMed ID: 7357545
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study of the antitumor activity and toxicity of the preparation, Peptichemio].
    Balitskiĭ KP; Veksler IG; Tsapenko VF
    Vopr Onkol; 1979; 25(7):105. PubMed ID: 483671
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards.
    Godenèche D; Madelmont JC; Moreau MF; Plagne R; Meyniel G
    Cancer Chemother Pharmacol; 1980; 5(1):1-9. PubMed ID: 7460189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA damage and mutagenesis induced by nitrogen mustards.
    Povirk LF; Shuker DE
    Mutat Res; 1994 Dec; 318(3):205-26. PubMed ID: 7527485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dechlorination of L-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content.
    Suzukake K; Vistica BP; Vistica DT
    Biochem Pharmacol; 1983 Jan; 32(1):165-7. PubMed ID: 6830612
    [No Abstract]   [Full Text] [Related]  

  • 30. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
    Catsoulacos P; Catsoulacos D
    Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of L-alpha-amino-gamma-guanidinobutyric acid on melphalan therapy of the L1210 murine leukemia.
    Vistica DT; Rabon A; Rabinovitz M
    Cancer Lett; 1979 May; 6(6):345-50. PubMed ID: 455272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor interaction with the antitumor agent estradiol mustard.
    Shepherd RE; Huff K; McGuire WL
    J Natl Cancer Inst; 1974 Sep; 53(3):895-7. PubMed ID: 4370003
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards.
    O'Connor PM; Kohn KW
    Cancer Commun; 1990; 2(12):387-94. PubMed ID: 2265064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. POLYPEPTIDES FROM P-PHENYLALANINE MUSTARD.
    MOSHER CW; IWAMOTO RH; ACTON EM; GOODMAN L
    J Med Chem; 1964 Sep; 7():650-2. PubMed ID: 14233180
    [No Abstract]   [Full Text] [Related]  

  • 35. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
    Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
    Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
    Goldenberg GJ
    Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a membrane sulfhydryl associated with resistance to melphalan in a murine L1210 leukemia line.
    Fisher JM; Naujokaitis AS; Uehara Y; Rabinovitz M
    Biochem Biophys Res Commun; 1983 Dec; 117(3):670-6. PubMed ID: 6667269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentrative uptake of melphalan, a cancer chemotherapeutic agent which is transported by the leucine-preferring carrier system.
    Vistica DT; Rabinovitz M
    Biochem Biophys Res Commun; 1979 Feb; 86(3):929-32. PubMed ID: 426830
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells.
    Dufour M; Panasci LC; St Germain J; Boulet L
    Cancer Chemother Pharmacol; 1985; 15(2):125-31. PubMed ID: 4017161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.